A CLINICAL TRIAL TO MEASURE IMPAIEMENT OF QUALITY OF LIFE OF VITILIGO PATIENTS USING VITILIGO IMPACT SCALE
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Vitiligo, superficial fungal infections, pityriasis rosea, scabies, seborrheic dermatitis, polymorphic light eruptions
- Registration Number
- CTRI/2018/01/011504
- Lead Sponsor
- Shri B M Patil medical college hospital and research centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 153
Inclusion Criteria
1)Patients > 15years, suffering from any clinical type of vitiligo.
2)Patients with educational status of at least secondary level.
Exclusion Criteria
1)Patients suffering from mental and cognitive impairments
2)Patients with other major skin disorders along with vitiligo like psoriasis, severe acne vulgaris, alopecia, melasma, which are likely to result in psychological morbidities.
3)Patients with associated hypothyroidism which may cause a depressed mood.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VIS-22 is a valid quality of life measurement scale among patients with vitiligoTimepoint: 1 year
- Secondary Outcome Measures
Name Time Method VIS-22 is a valid, highly reliable and responsive scale to measure the impairment of QOL among vitiligo patients. The scale has better measurement properties compared to DLQI and Skindex-16 with vitiligo-specific questionsTimepoint: 1 year 6 months